These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 18159713

  • 1. [First choice drug for treatment of osteoporosis and the strategic points for choice of drugs].
    Soen S.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():325-8. PubMed ID: 18159713
    [No Abstract] [Full Text] [Related]

  • 2. [Prevention of fractures with therapeutic agents for osteoporosis].
    Hosoi T.
    Nihon Rinsho; 2004 Feb 28; 62 Suppl 2():596-601. PubMed ID: 15035197
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of osteoporosis: overview].
    Nakamura T.
    Nihon Rinsho; 2002 Mar 28; 60 Suppl 3():273-9. PubMed ID: 11979919
    [No Abstract] [Full Text] [Related]

  • 4. [Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front].
    MMW Fortschr Med; 2003 Jul 10; 145(27-28):63. PubMed ID: 14587198
    [No Abstract] [Full Text] [Related]

  • 5. [Evidence of raloxifene on postmenopausal osteoporosis].
    Okano H.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():374-80. PubMed ID: 18161135
    [No Abstract] [Full Text] [Related]

  • 6. [Evidence of risedronate for treatment of osteoporosis].
    Soen S.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():344-7. PubMed ID: 18161128
    [No Abstract] [Full Text] [Related]

  • 7. [Evidence for efficacy of active vitamin D3 as an anti-osteoporotic drug].
    Inoue D.
    Clin Calcium; 2008 Oct 28; 18(10):1469-75. PubMed ID: 18830044
    [Abstract] [Full Text] [Related]

  • 8. [A-TOP research group/JOINT-02].
    Kuroda T, Ohta H, Shiraki M, Miyakawa N, Hosoi T, Nakamura T, Fukunaga M, Orimo H.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():271-4. PubMed ID: 18161118
    [No Abstract] [Full Text] [Related]

  • 9. [Anabolic treatment for osteoporosis: PTH treatment].
    Kaji H, Sugimoto T.
    Clin Calcium; 2006 Sep 28; 16(9):1480-85. PubMed ID: 16951472
    [Abstract] [Full Text] [Related]

  • 10. [Osteoporosis therapy compared. More solid bones with bisphosphonates].
    MMW Fortschr Med; 2003 Aug 07; 145(31-32):55. PubMed ID: 14524081
    [No Abstract] [Full Text] [Related]

  • 11. [Drug therapy of secondary osteoporosis: glucocorticoid-induced osteoporosis].
    Soen S.
    Nihon Rinsho; 2009 May 07; 67(5):985-90. PubMed ID: 19432121
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of primary osteoporosis in men].
    Yamaguchi T, Sugimoto T.
    Clin Calcium; 2006 Mar 07; 16(3):474-9. PubMed ID: 16508131
    [Abstract] [Full Text] [Related]

  • 13. [Concurrent treatment of osteoporosis including vitamin K].
    Kobayashi S, Shiraki M, Takaoka K.
    Clin Calcium; 2007 Nov 07; 17(11):1731-7. PubMed ID: 17982194
    [Abstract] [Full Text] [Related]

  • 14. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
    Soen S.
    Clin Calcium; 2009 Jan 07; 19(1):44-53. PubMed ID: 19122264
    [Abstract] [Full Text] [Related]

  • 15. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
    Soen S.
    Clin Calcium; 2006 Nov 07; 16(11):1788-96. PubMed ID: 17079844
    [Abstract] [Full Text] [Related]

  • 16. Pharmacotherapeutic management of osteoprosis and osteopenia.
    Alexander IM.
    Nurse Pract; 2009 Jun 07; 34(6):30-40; quiz 41. PubMed ID: 19474629
    [No Abstract] [Full Text] [Related]

  • 17. [Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Advances in clinical trials for osteoporosis in Japan].
    Nakamura T.
    Clin Calcium; 2011 Dec 07; 21(12):145-51. PubMed ID: 22133833
    [Abstract] [Full Text] [Related]

  • 18. [Defining the role of raloxifene as a therapeutic agent for postmenopausal osteoporosis: focus on its pharmacological properties].
    Ohta H.
    Clin Calcium; 2004 Oct 07; 14(10):73-80. PubMed ID: 15577135
    [Abstract] [Full Text] [Related]

  • 19. [Absolute risk for fracture and WHO guideline. Pharmacological intervention to prevent osteoporotic fractures in the elderly].
    Hosoi T, World Health Organization.
    Clin Calcium; 2007 Jul 07; 17(7):1098-104. PubMed ID: 17607078
    [Abstract] [Full Text] [Related]

  • 20. Latest innovation in the treatment of osteoporosis: SERMs and the role of parathyroid hormone.
    Thiebaud D.
    J Med Assoc Thai; 2004 Oct 07; 87 Suppl 3():S124-5. PubMed ID: 21213508
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.